Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01925885 · ClinicalTrials.gov registry record · NA
Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)
A NA study, sponsored by Indiana University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01925885 is a NA study that was terminated before completion, run by Indiana University. The registered enrollment target is 1 participants.
The verdict
NCT01925885, a NA study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
* Hypothesis: Focal Impulse and Rotor Modulation (FIRM) will substantially reduce or eliminate clinical atrial fibrillation in subjects with accepted indications for catheter ablation of paroxysmal AF, compared to standard pulmonary vein isolation. * Summary: This is a prospective randomized study to assess the safety and effectiveness of FIRM procedures only, versus standard Pulmonary Vein Isolation (PVI) procedures for the treatment of symptomatic paroxysmal atrial fibrillation.
Interventions
- PROCEDURE PVI Ablation
- PROCEDURE FIRM Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2013-09 |
| Est. Completion | 2015-12-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01925885
The ClinicalTrials.gov registry entry for NCT01925885 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PVI Ablation is the first listed.
NCT01925885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01925885 about?
NCT01925885 is a clinical study titled "Focal Impulse and Rotor Modulation Ablation Trial for Treatment of Paroxysmal Atrial Fibrillation (FIRMAT-PAF)". * Hypothesis: Focal Impulse and Rotor Modulation (FIRM) will substantially reduce or eliminate clinical atrial fibrillation in subjects with accepted indications for catheter ablation of paroxysmal AF, compared to standard pulmonary vein isolation. * Summary: This is a prospective randomized study t...
What is the current status of trial NCT01925885?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2013-09. Estimated completion is 2015-12-23.
What interventions are being tested in trial NCT01925885?
The interventions under investigation include: PVI Ablation (PROCEDURE), FIRM Ablation (PROCEDURE).
Who is sponsoring clinical trial NCT01925885?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.